BIODESIX INC Quarterly Operating Income (Loss) in USD from Q3 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Biodesix Inc quarterly/annual Operating Income (Loss) history and growth rate from Q3 2019 to Q3 2024.
  • Biodesix Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$8.59M, a 19.8% decline year-over-year.
  • Biodesix Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$34.7M, a 28.2% increase year-over-year.
  • Biodesix Inc annual Operating Income (Loss) for 2023 was -$41.3M, a 18.3% increase from 2022.
  • Biodesix Inc annual Operating Income (Loss) for 2022 was -$50.6M, a 23.6% decline from 2021.
  • Biodesix Inc annual Operating Income (Loss) for 2021 was -$40.9M, a 78.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$34.7M -$8.59M -$1.42M -19.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-01
Q2 2024 -$33.3M -$8.24M +$2.69M +24.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$36M -$11M +$5.35M +32.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$41.3M -$6.87M +$7.02M +50.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-01
Q3 2023 -$48.4M -$7.17M +$3.44M +32.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-01
Q2 2023 -$51.8M -$10.9M +$699K +6.01% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$52.5M -$16.4M -$1.91M -13.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$50.6M -$13.9M -$2.21M -18.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-01
Q3 2022 -$48.4M -$10.6M +$2.48M +19% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$50.9M -$11.6M -$1.04M -9.81% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$49.8M -$14.5M -$8.88M -159% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$40.9M -$11.7M -$9.03M -340% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-06
Q3 2021 -$31.9M -$13.1M -$6.85M -110% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$25.1M -$10.6M -$4.97M -88.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$20.1M -$5.58M +$2.84M +33.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$22.9M -$2.65M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 -$6.24M +$2.79M +30.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$5.62M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$8.42M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 -$9.03M Jul 1, 2019 Sep 30, 2019 10-Q 2020-12-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.